In the remaining patients (50–40%), no SMAD4 or BMPR1A gene mutations are detected, strongly suggesting the involvement of other potential mutations in the occurrence and pathogenesis of JPS. This evidence concerns the gene SMAD4 and juvenile polyposis syndrome.